Notably, daily treatment of HE recovered the blood estrogen level and thereby improved the osteoporotic changes, as evidenced by decreased blood ALP activity and bone TRAP immunoreactivity as well as restored trabecular bone mass with high BMD and BMC. Here, ACP5 is linked to hereditary elliptocytosis.